SHARE-BASED COMPENSATION (SARS Activity) (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)	12 Months Ended
	Jan. 30, 2016	Jan. 31, 2015
Number of Underlying Shares Outstanding [Roll Forward]
Number of Underlying Shares, Outstanding (in shares)	5,301,115	8,953,675
Number of Underlying Shares, Granted (in shares)	715,858
Number of Underlying Shares, Exercised (in shares)	(1,550,000)
Number of Underlying Shares, Forfeited or expired (in shares)	(2,818,418)
Weighted-Average Exercise Price [Roll Forward]
Weighted-Average Exercise Price, Outstanding (in dollars per share)	$ 45.02	$ 40.28
Weighted-Average Grant Date Fair Value, Granted (in dollars per share)	21.71
Weighted-Average Exercise Price, Exercised (in dollars per share)	22.23
Weighted-Average Exercise Price, Forfeited or exercised (in dollars per share)	$ 36.58
Aggregate Intrinsic Value, Outstanding	$ 2,827,754
Weighted-Average Remaining Contractual Life, Outstanding	3 years 7 months
Number of Underlying Shares, Stock appreciation rights exercisable (in shares)	4,288,337
Weighted-Average Exercise Price, Stock appreciation rights exercisable (in dollars per share)	$ 48.75
Aggregate Intrinsic Value, Stock appreciation rights exercisable	$ 11,657
Weighted- Average Remaining Contractual Life, Stock appreciation rights exercisable	2 years 4 months
Number of Underlying Shares, Stock appreciation rights expected to become exercisable (in shares)	897,471
Weighted-Average Exercise Price, Stock appreciation rights expected to become exercisable (in dollars per share)	$ 29.73
Aggregate Intrinsic Value, Stock appreciation rights expected to become exercisable	$ 2,352,008
Weighted-Average Remaining Contractual Life, Stock appreciation rights expected to become exercisable	8 years 7 months